@article{fdi:010076636,
  title = {{H}epatitis {B} virus prevalence and vaccination in men who have sex with men in {W}est {A}frica ({C}oh{MSM} {ANRS} 12324-expertise {F}rance)},
  author = {{D}ah, {T}. {T}. {E}. and {C}ouderc, {C}. and {C}oulibaly, {A}. and {K}ouame, {M}. {J}. {B}. and {A}gboyibor, {M}. {K}. and {T}raore, {I}. and {M}aradan, {G}. and {C}astro, {D}. {R}. and {M}ensah, {E}. and {A}noma, {C}. and {K}eita, {B}. {D}. and {S}pire, {B}. and {L}aurent, {C}hristian and {G}ranouillac, {B}runo and {I}zard, {S}uzanne and {M}arch, {L}aura and {P}eeters, {M}artine and {S}errano, {L}. and {B}erenger, {C}. and {B}ourrelly, {M}. and {C}oulaud, {P}. {J}. and {M}ora, {M}. and {S}agaon {T}eyssier, {L}uis and {B}ernier, {A}. and {P}alvadeau, {P}. and {C}amara, {D}. and {C}isse, {O}. and {D}iallo, {F}. and {D}iarra, {M}. and {K}eita, {A}. {A}. and {M}aiga, {K}. and {O}uologuem, {A}. and {T}raore, {F}. and {A}ka, {N}. {T}. and {Y}oro, {S}. {A}. {B}. and {C}oulibaly, {N}. {H}. and {K}otchi, {R}. and {K}ouabenan, {P}. and {L}okrou, {K}. {J}. and {N}'{G}uessan, {F}. {D}. and {C}oulibaly, {C}. and {I}lboudo, {O}. and {O}uedraogo, {J}. and {O}uedraogo, {M}. and {T}hio, {E}. and {T}oure, {J}. {R}. and {T}raore, {A}. and {T}raore, {I}. and {Y}ougbare, {F}. and {A}gbomadji, {K}. {K}. {S}. and {A}ttiogbe, {M}. and {B}adjassim, {A}. {M}. and {E}kon, {A}. {L}. and {K}okouba, {A}. and {T}ablissi, {D}. {J}. {S}. and {Y}aka, {K}. {J}. and {D}agnra, {C}. {A}. {Y}. and {C}oh{MSM} {S}tudy {G}roup,},
  editor = {},
  language = {{ENG}},
  abstract = {{B}ackground. {A}lthough men who have sex with men ({MSM}) are at high risk of hepatitis {B} virus ({HBV}) infection, they do not have access to vaccination in {W}est {A}frica, which is a highly endemic region. {W}e investigated {HBV} prevalence and associated factors, as well as acceptability and difficulties of vaccination in {MSM} enrolled in an operational research program in {B}urkina {F}aso, {C}ote d'{I}voire, {M}ali, and {T}ogo. {M}ethods. {W}e followed up 779 {MSM} in 2015-2018. {P}articipants who were negative for both hepatitis {B} surface antigen ({HB}s{A}g) and antibodies (anti-{HB}s) at enrollment were offered {HBV} vaccination. {F}actors associated with {HBV} infection were identified using logistic regression models. {R}esults. {O}verall, {HBV} prevalence was 11.2% (95% confidence interval [{CI}], 9.0%-13.6%). {I}t was lower in {T}ogo than in {C}ote d'{I}voire (2.7% vs 17.3%; adjusted odds ratio [a{OR}], 0.12; 95% {CI}, 0.02-0.28) and higher in participants with 6+ recent male sexual partners (21.0% vs 9.3%; a{OR}, 1.48; 95% {CI}, 1.12-1.97). {O}f 528 participants eligible for vaccination, 484 (91.7%) were willing to be vaccinated and received at least 1 dose (ranging from 68.2% in {A}bidjan to 96.4% in {B}amako; {P} < .001). {O}f the latter, 390 (80.6%) received 3 or 4 doses. {T}he proportion of participants for whom the minimum required time between each dose was respected ranged from 10.9% in {B}amako to 88.6% in {L}ome ({P} < .001). {C}onclusions. {MSM} in {W}est {A}frica should be targeted more for {HBV} screening and vaccination. {A}lthough vaccination is well accepted by {MSM}, greater training of health care workers and education of {MSM} are required.},
  keywords = {{A}frica ; hepatitis {B} ; men who have sex with men ; prevalence ; vaccination ; {BAMAKO} ; {MALI} ; {ABIDJAN} ; {COTE} {D}’{IVOIRE} ; {OUAGADOUGOU} ; {BURKINA} {FASO} ; {LOME} ; {TOGO}},
  booktitle = {},
  journal = {{O}pen {F}orum {I}nfectious {D}iseases},
  volume = {6},
  numero = {7},
  pages = {ofz249 [9 p.]},
  ISSN = {2328-8957},
  year = {2019},
  DOI = {10.1093/ofid/ofz249},
  URL = {https://www.documentation.ird.fr/hor/fdi:010076636},
}